Woodstock Sterile Solutions
Woodstock Sterile Solutions is a leading global provider of aseptic pharmaceutical development and manufacturing solutions, specializing in blow-fill-seal technology for sterile products. With over 50 years of experience, the company focuses on complex formulations, biologics, and high-potent compounds, supporting healthcare companies from clinical to commercial stages. Committed to quality, innovation, and sustainability, Woodstock aims to be the best development and commercial partner in the industry, delivering life-enhancing molecules from benchtop to patient.
Industries
Nr. of Employees
large (251-1000)
Woodstock Sterile Solutions
Woodstock, Alabama, United States
Patents
Preparation of an oil-in-water emulsion for polymer stabilized pharmaceutical formulations
US-10413508-B2
View Details
Preparation of an oil-in-water emulsion for polymer stabilized pharmaceutical formulations
US-10413508-B2
View DetailsProducts
Sterile primary container formats formed by blow-fill-seal
Unit-dose and multi-dose primary containers produced by blow-fill-seal (ampules, vials, and bottles) available in multiple resins and customized designs.
Blow-Fill-Seal
An aseptic technology and contract manufacturing service used to package pharmaceutical, healthcare, and point-of-care diagnostic products by forming, filling, and sealing containers in a continuous automated process.
Sterile Blow-Fill-Seal Contract Development and Manufacturing Services
Comprehensive aseptic blow-fill-seal (BFS) contract development and manufacturing (CDMO) services for pharmaceutical, biological, ophthalmic, and respiratory products from benchtop formulation to commercial scale.
Blow-Fill-Seal Manufacturing Capability
Comprehensive production environments supporting sterile and non-sterile liquid formulations through customizable specialty fill-finish solutions.
Blow-Fill-Seal Manufacturing Facility
A 430,000 square foot manufacturing facility featuring over 30 blow-fill-seal suites capable of producing nearly 1 billion BFS units annually, offering contract manufacturing and sterile fill-finish services.
Advanced Aseptic Manufacturing
Contract manufacturing services utilizing blow-fill-seal (BFS) technology to form, fill, and seal liquid therapeutic primary containers in a continuous, automated process.
Sterile primary container formats formed by blow-fill-seal
Unit-dose and multi-dose primary containers produced by blow-fill-seal (ampules, vials, and bottles) available in multiple resins and customized designs.
Blow-Fill-Seal
An aseptic technology and contract manufacturing service used to package pharmaceutical, healthcare, and point-of-care diagnostic products by forming, filling, and sealing containers in a continuous automated process.
Sterile Blow-Fill-Seal Contract Development and Manufacturing Services
Comprehensive aseptic blow-fill-seal (BFS) contract development and manufacturing (CDMO) services for pharmaceutical, biological, ophthalmic, and respiratory products from benchtop formulation to commercial scale.
Blow-Fill-Seal Manufacturing Capability
Comprehensive production environments supporting sterile and non-sterile liquid formulations through customizable specialty fill-finish solutions.
Blow-Fill-Seal Manufacturing Facility
A 430,000 square foot manufacturing facility featuring over 30 blow-fill-seal suites capable of producing nearly 1 billion BFS units annually, offering contract manufacturing and sterile fill-finish services.
Advanced Aseptic Manufacturing
Contract manufacturing services utilizing blow-fill-seal (BFS) technology to form, fill, and seal liquid therapeutic primary containers in a continuous, automated process.
Services
End-to-end services from formulation development through commercial aseptic BFS manufacturing and packaging.
Formulation labs, analytical method development, and characterization to support stability, release and regulatory filings.
Small-batch clinical manufacturing and seamless scale-up to pilot and commercial production with GMP practices.
On-site QC lab services including HPLC/UPLC, particle analysis, method validation, release and stability testing.
Secondary finishing, bulk packaging, device kitting and inline serialization integrated with primary BFS operations.
End-to-end services from formulation development through commercial aseptic BFS manufacturing and packaging.
Formulation labs, analytical method development, and characterization to support stability, release and regulatory filings.
Small-batch clinical manufacturing and seamless scale-up to pilot and commercial production with GMP practices.
On-site QC lab services including HPLC/UPLC, particle analysis, method validation, release and stability testing.
Secondary finishing, bulk packaging, device kitting and inline serialization integrated with primary BFS operations.
Expertise Areas
- Blow-fill-seal aseptic manufacturing
- Formulation development for complex liquid therapeutics
- Fill–finish and scale-up from clinical to commercial
- Analytical testing, method development and stability programs
Key Technologies
- Blow-fill-seal (BFS) aseptic processing
- Temperature-controlled BFS processing
- HPLC / UPLC analytical systems
- Particle size and zeta potential analysis
News & Updates
Investment to expand BFS capabilities with a new high-speed bottle packaging line supporting 85 million units annually.
The company completed its first diagnostics project, demonstrating BFS benefits for diagnostic testing, including COVID-19 home test kits.
Sheila Moran, with over 30 years of industry experience, joins as the company's first SVP of Quality to enhance quality programs.
Courtney Sanen, with nearly 20 years of financial and operations management experience, joins as CFO to support growth.
The expansion doubles the size of the lab, enabling in-house method development, testing, and product release.
Secured a patent for a process that minimizes temperature impact on thermally sensitive molecules, including biologics.
Investment to expand BFS capabilities with a new high-speed bottle packaging line supporting 85 million units annually.
The company completed its first diagnostics project, demonstrating BFS benefits for diagnostic testing, including COVID-19 home test kits.
Sheila Moran, with over 30 years of industry experience, joins as the company's first SVP of Quality to enhance quality programs.
Courtney Sanen, with nearly 20 years of financial and operations management experience, joins as CFO to support growth.
The expansion doubles the size of the lab, enabling in-house method development, testing, and product release.
Secured a patent for a process that minimizes temperature impact on thermally sensitive molecules, including biologics.